血管画像システム市場- 世界の産業規模、シェア、動向、機会、予測、技術別、施術別、エンドユーザー地域別、競合別、2019年～2029年

世界の血管画像システム市場は、2023年に62億9,000万米ドルと評価され、2029年までのCAGRは3.56%で、予測期間中に力強い成長が予測されています。

世界の血管画像システム市場は、広範な医療画像産業の中でもダイナミックで急速に発展している分野です。血管画像システムは、アテローム性動脈硬化症、動脈瘤、末梢動脈疾患など、広範な心血管および血管疾患の診断とモニタリングにおいて重要な役割を果たしています。この市場には、ヘルスケア専門家が血管や循環系を可視化し、血管疾患の早期発見と管理に役立つ多様な技術や製品が含まれています。

世界の血管画像システム市場の成長を後押ししている要因はいくつかあります。まず、心血管疾患の有病率の上昇と高齢化により、正確で高度な診断ツールに対する需要が高まっています。さらに、血管画像診断の技術的進歩により、より正確で低侵襲な施術が可能になり、患者のリスクを低減し、診断能力を高めています。さらに、疾病の早期発見と予防ヘルスケアに重点を置く傾向が強まっており、これが血管画像システムの採用を後押ししています。

この市場には、超音波、磁気共鳴血管造影（MRA）、コンピュータ断層撮影（CTA）、デジタルサブトラクション血管造影（DSA）など、さまざまな種類の血管画像モダリティが含まれます。各モダリティは固有の利点を持ち、異なる臨床シナリオで使用されるため、市場の多様性に寄与しています。

市場促進要因

心血管疾患の有病率の増加

イメージング技術の進歩

疾患の早期発見の重視

主な市場課題

コストとアクセシビリティ

放射線被曝

主な市場動向

低侵襲手術

予防ヘルスケアの台頭

セグメント別洞察

技術別洞察

施術別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 血管画像システムの世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別（MRI、CTスキャン、超音波、核医学画像、X線）
  • 施術別（冠動脈造影、末梢血管造影、血管超音波、脳血管造影、その他）
  • エンドユーザー別（病院クリニック、外来診療センター、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第5章 アジア太平洋の血管画像システム市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別
  • 施術別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の血管画像システム市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別
  • 施術別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の血管画像システム市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別
  • 施術別
  • エンドユーザー別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の血管画像システム市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別
  • 施術別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの血管画像システム市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 技術別
  • 施術別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 合併買収（もしあれば）
• 製品上市（もしあれば）
• 最近の動向

第12章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第13章 競合情勢

• Siemens Healthineers AG
• GE Healthcare
• Koninklijke Philips N.V.
• Hitachi Medical Corporation
• Samsung Medison Co., Ltd.
• Shimadzu Medical Systems
• Hologic Inc.
• Abbott Laboratories Inc.
• OrthoScan, Inc.
• Canon Medical Systems Corporation

第14章 戦略的提言

第15章 免責事項

Global Vascular Imaging Systems Market was valued at USD 6.29 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 3.56% through 2029. The Global Vascular Imaging Systems Market is a dynamic and rapidly evolving sector within the broader medical imaging industry. Vascular imaging systems play a crucial role in diagnosing and monitoring a wide range of cardiovascular and vascular conditions, including atherosclerosis, aneurysms, and peripheral artery disease. This market encompasses a diverse array of technologies and products that enable healthcare professionals to visualize blood vessels and circulatory systems, aiding in the early detection and management of vascular diseases.

Several factors are driving the growth of the global vascular imaging systems market. Firstly, the rising prevalence of cardiovascular diseases, coupled with an aging population, has increased the demand for accurate and advanced diagnostic tools. Additionally, technological advancements in vascular imaging have led to more precise and minimally invasive procedures, reducing patient risk and enhancing diagnostic capabilities. Furthermore, there is a growing emphasis on early disease detection and preventative healthcare, which is bolstering the adoption of vascular imaging systems.

The market includes various types of vascular imaging modalities, such as ultrasound, magnetic resonance angiography (MRA), computed tomography angiography (CTA), and digital subtraction angiography (DSA). Each modality offers specific advantages and is used in different clinical scenarios, contributing to the market's diversity.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases (CVDs) is a powerful driver behind the growth of the global vascular imaging systems market. Cardiovascular diseases encompass a wide range of conditions, including coronary artery disease, atherosclerosis, peripheral artery disease, and stroke, which collectively represent one of the leading causes of mortality and morbidity worldwide. As populations age and lifestyles become more sedentary with unhealthy dietary habits, the incidence of CVDs is on the rise.

Vascular imaging systems serve as an indispensable tool for diagnosing and monitoring these conditions. They enable healthcare professionals to visualize blood vessels and the circulatory system, facilitating the early detection of vascular abnormalities such as arterial blockages or the presence of aneurysms. With the growing burden of cardiovascular diseases, there is an escalating demand for highly accurate and advanced diagnostic technologies, further fueling the adoption of vascular imaging systems.

The impact of the increasing prevalence of cardiovascular diseases is not limited to developed countries; emerging economies are also grappling with the rise in CVD cases. Countries in Asia, Latin America, and Africa are witnessing an uptick in lifestyle-related risk factors such as obesity, diabetes, and hypertension, all of which contribute to the development of cardiovascular diseases. This phenomenon is particularly pronounced in rapidly urbanizing areas, where sedentary lifestyles and unhealthy eating habits are becoming more prevalent.

To combat the escalating cardiovascular disease crisis, healthcare systems and providers are investing in state-of-the-art vascular imaging technologies to enable early diagnosis and treatment planning. Vascular imaging not only helps save lives by detecting potentially life-threatening conditions in their early stages but also reduces the overall healthcare burden and cost associated with the treatment of advanced CVDs.

Technological Advancements in Imaging

Technological advancements in imaging have been instrumental in propelling the growth of the global vascular imaging systems market. These innovations have revolutionized the field of medical imaging, enhancing the accuracy, efficiency, and overall capabilities of vascular imaging systems. As a result, healthcare providers are increasingly adopting these advanced technologies, driving the expansion of the market.

High-resolution imaging techniques have played a pivotal role in transforming vascular imaging. For example, the development of 3D and 4D ultrasound has provided healthcare professionals with the ability to visualize blood vessels and circulatory systems in greater detail, enabling them to identify vascular abnormalities more accurately. Enhanced visualization is crucial for making precise diagnoses and planning appropriate treatment strategies.

Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) have also benefited from significant technological improvements. These modalities offer non-invasive and highly detailed imaging of blood vessels, aiding in the diagnosis of conditions such as atherosclerosis, aneurysms, and vascular obstructions. Advancements in these imaging techniques have made them faster, more comfortable for patients, and less reliant on contrast agents, contributing to their wider adoption.

The integration of artificial intelligence (AI) and machine learning algorithms into vascular imaging systems has further amplified the market's growth. AI-powered algorithms can assist in the interpretation of images, automating tasks like image segmentation, vessel tracking, and the identification of abnormalities. This not only reduces the time required for data analysis but also enhances the precision of diagnoses, allowing for quicker and more accurate treatment decisions.

AI-driven technologies can assist in predicting disease progression and the potential risk of vascular events, offering a valuable tool for preventive medicine. The use of AI in vascular imaging systems is increasingly seen as a game-changer, as it complements the skills of healthcare professionals and improves patient outcomes.

Emphasis on Early Disease Detection

The emphasis on early disease detection is a significant driver behind the growth of the global vascular imaging systems market. Healthcare systems and providers worldwide are increasingly recognizing the importance of identifying and diagnosing vascular diseases at their earliest stages to improve patient outcomes and reduce the overall burden on healthcare resources. This shift in approach has led to a growing demand for vascular imaging systems, which play a crucial role in the early detection of vascular abnormalities.

Vascular diseases, including atherosclerosis, peripheral artery disease, and aneurysms, can be asymptomatic in their early stages, making them difficult to diagnose without advanced imaging. Vascular imaging systems provide a non-invasive and highly accurate means of detecting and diagnosing these conditions, allowing healthcare professionals to intervene before they progress to more severe and life-threatening stages. Early detection not only saves lives but also minimizes the need for complex and costly interventions, which can have a profound impact on the healthcare system's efficiency and cost-effectiveness.

The emphasis on early disease detection is also in line with the growing interest in preventive medicine. Patients and healthcare providers are increasingly focused on identifying health risks before they escalate into severe conditions. Vascular imaging is an integral component of preventive health check-ups, enabling physicians to evaluate a patient's vascular health and assess the risk of future complications, such as heart attacks or strokes. This preventive approach can significantly improve patient outcomes and quality of life, fostering greater patient engagement and loyalty.

As the global population continues to age and face an increasing prevalence of cardiovascular risk factors, such as obesity and diabetes, the importance of early disease detection becomes even more pronounced. Healthcare providers are investing in advanced vascular imaging systems to meet the rising demand for early diagnosis and timely intervention.

Key Market Challenges

Cost and Accessibility

The global vascular imaging systems market has shown remarkable growth and innovation over the years, offering advanced diagnostic capabilities for a wide range of cardiovascular and vascular conditions. However, the market faces significant challenges related to cost and accessibility, which can impede its broader adoption and impact patient care.

One of the primary challenges hampering the vascular imaging systems market is the high cost associated with these advanced medical technologies. Vascular imaging systems, including ultrasound machines, magnetic resonance angiography (MRA) scanners, and computed tomography angiography (CTA) equipment, are sophisticated and complex pieces of medical equipment. Their development, manufacturing, and maintenance require substantial financial investments, leading to high price tags.

This cost burden can pose a significant barrier to entry for healthcare facilities, particularly those in resource-constrained environments and emerging economies. Smaller clinics and rural healthcare settings may struggle to secure the funding required to acquire and maintain vascular imaging systems. As a result, many patients in these areas may not have access to these critical diagnostic tools, limiting the timely and accurate diagnosis of vascular conditions.

The high cost of vascular imaging systems can also exacerbate disparities in healthcare access, both within and between countries. Developed nations with robust healthcare budgets tend to adopt advanced vascular imaging technologies more readily, while developing regions may lag behind due to budget constraints.

Radiation Exposure

While vascular imaging systems have revolutionized the diagnosis and management of cardiovascular and vascular diseases, they are not without their challenges. One of the significant concerns hindering the global vascular imaging systems market is the potential for radiation exposure, primarily associated with imaging modalities such as computed tomography angiography (CTA) and digital subtraction angiography (DSA).

Vascular imaging is indispensable for diagnosing and monitoring vascular conditions, offering detailed insights into blood vessels' structure and function. However, imaging techniques involving ionizing radiation, like CTA and DSA, have raised concerns about the safety of patients and healthcare professionals who are exposed to radiation during these procedures.

Prolonged or excessive exposure to ionizing radiation can have adverse health effects, including an increased risk of cancer, particularly for healthcare workers who perform these procedures regularly. Patient safety is a top priority in healthcare, and the potential risks associated with radiation exposure must be carefully managed.

To address this challenge, significant efforts have been made to minimize radiation exposure while maintaining the diagnostic quality of vascular imaging. This includes optimizing imaging protocols to reduce radiation doses, using advanced hardware and software solutions that allow for lower-dose imaging, and implementing stricter safety guidelines in healthcare facilities.

Awareness and education on the risks and benefits of vascular imaging are crucial. Healthcare providers must ensure that patients are well-informed about the procedures and associated radiation exposure, enabling them to make informed decisions about their healthcare. This shared decision-making process helps strike a balance between obtaining the necessary diagnostic information and minimizing radiation exposure, ultimately ensuring the safety and well-being of patients.

Key Market Trends

Minimally Invasive Procedures

Minimally invasive procedures are a significant driver behind the growth of the global vascular imaging systems market. These procedures have gained immense popularity due to their reduced patient risk, shorter recovery times, and improved outcomes when compared to traditional open surgeries. As a result, healthcare providers increasingly rely on vascular imaging systems that allow for real-time visualization during these minimally invasive interventions.

Vascular imaging plays a pivotal role in these procedures, offering healthcare professionals a clear view of blood vessels and circulatory systems, facilitating precise navigation and monitoring during the intervention. For example, during angioplasty, which involves opening narrowed or blocked arteries, vascular imaging systems provide real-time feedback on the progress of the procedure, ensuring that the angioplasty balloon or stent is accurately positioned and deployed. This minimally invasive approach significantly reduces the risks associated with open surgery, including infection and longer hospital stays.

In addition to angioplasty, minimally invasive procedures include stent placement, embolization for treating aneurysms, and endovascular repair of aortic aneurysms, among others. These procedures have become the preferred choice for both patients and healthcare providers, driven by the desire for quicker recovery, less pain, and improved overall quality of life.

The growth of the minimally invasive procedures trend has led to an increased adoption of vascular imaging systems, which enable real-time visualization and navigation during these interventions. Patients benefit from less invasive treatments and reduce post-operative discomfort, while healthcare providers appreciate the ability to accurately and continuously monitor procedures. This trend is poised to continue driving the expansion of the global vascular imaging systems market, as the demand for these technologies aligns with the broader healthcare shift towards patient-centered care, enhanced safety, and improved patient outcomes.

Rise in Preventative Healthcare

The rise in preventative healthcare has emerged as a significant driver behind the growth of the global vascular imaging systems market. Preventative healthcare places a strong emphasis on early disease detection and intervention, encouraging individuals to seek regular health check-ups and screenings. Vascular imaging systems play a pivotal role in this paradigm shift, enabling healthcare professionals to assess vascular health and identify potential risks before they escalate into severe conditions.

Vascular imaging systems, including modalities like ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA), offer non-invasive and highly accurate means of detecting and diagnosing vascular abnormalities such as arterial blockages, aneurysms, and peripheral artery disease. These technologies provide detailed insights into blood vessels and circulatory systems, allowing healthcare providers to evaluate the degree of vascular damage and assess the risk of future complications, such as heart attacks or strokes.

Preventative healthcare not only empowers patients to take an active role in managing their health but also fosters the adoption of vascular imaging systems in outpatient clinics, diagnostic centers, and primary care settings. Patients benefit from early detection and timely intervention, which can significantly improve their long-term health outcomes and reduce the burden of advanced vascular diseases.

Healthcare providers increasingly recognize the value of vascular imaging in preventive healthcare, as it aligns with the broader goal of achieving better patient care and outcomes. The demand for accurate and advanced diagnostic tools that support early disease detection is expected to remain robust, further driving the growth of the global vascular imaging systems market.

Segmental Insights

Technique Insights

Based on the technique, CT scan emerged as the dominant segment in the global market for globalvascular imaging systems in 2023.CT angiography provides high-resolution, three-dimensional images of blood vessels, offering exceptional detail and clarity in visualizing vascular structures. This level of detail is crucial in diagnosing and assessing various vascular conditions. CT scans are relatively quick, providing fast results. This speed is advantageous in emergency situations where rapid assessment of vascular issues is critical, such as in cases of trauma or stroke. CT scanners are widely available in healthcare facilities and can be used to image a wide range of vascular regions, including the coronary arteries, brain, extremities, and more. They are a versatile tool for diagnosing vascular diseases in various parts of the body.

Procedure Insights

Based on the procedure, coronary angiography emerged as the dominant segment in the global market for global vascular imaging systems market in 2023.Coronary angiography is primarily used for diagnosing and evaluating coronary artery disease (CAD), one of the most prevalent and life-threatening cardiovascular conditions worldwide. As the incidence of CAD continues to rise, there is an increasing demand for coronary angiography to assess and guide the treatment of these patients. Coronary angiography is considered the gold standard for visualizing coronary arteries and assessing the presence of blockages or stenosis. It provides detailed and accurate images of the coronary vessels, enabling healthcare professionals to make precise diagnoses and treatment decisions. Beyond diagnosis, coronary angiography also plays a crucial role in guiding interventional procedures such as angioplasty and stent placement. These minimally invasive procedures have become the preferred approach for treating coronary artery disease, further boosting the demand for coronary angiography.

Regional Insights

North America emerged as the dominant region in the global vascular imaging systems market in 2023, holding the largest market share. North American countries, particularly the United States, invest heavily in research and development in the healthcare sector. This investment fosters innovation, leading to the introduction of advanced vascular imaging technologies and the continuous improvement of existing systems. Access to healthcare services and coverage is relatively high in North America. The majority of the population has health insurance, which facilitates the utilization of medical services, including vascular imaging. This financial support ensures that patients can receive the necessary diagnostic tests and treatments, further driving market demand.

Key Market Players

Siemens Healthineers AG

GE Healthcare

Koninklijke Philips N.V.

Hitachi Medical Corporation

Samsung Medison Co., Ltd.

Shimadzu Medical Systems

Hologic Inc.

Abbott Laboratories Inc.

OrthoScan, Inc.

Canon Medical Systems Corporation

Report Scope:

In this report, the Global Vascular Imaging Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Imaging Systems Market,By Technique:

• MRI
• CT scan
• Ultrasound
• Nuclear Imaging
• X Ray

Vascular Imaging Systems Market,By Procedure:

• Coronary Angiography
• Peripheral Angiography
• Vascular Ultrasound
• Cerebral Angiography
• Others

Vascular Imaging Systems Market,By End User:

• Hospitals clinics
• Ambulatory Surgical Services
• Others

Vascular Imaging Systems Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Imaging Systems Market.

Available Customizations:

Global Vascular Imaging Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Vascular Imaging Systems Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Technique (MRI, CT scan, Ultrasound, Nuclear Imaging, X Ray)
  • 4.2.2.By Procedure(Coronary Angiography, Peripheral Angiography, Vascular Ultrasound, Cerebral Angiography, Others)
  • 4.2.3.By End-User (Hospitals Clinics, Ambulatory care Centers, Others)
  • 4.2.4.By Region
  • 4.2.5.By Company (2023)
• 4.3.Market Map

5.Asia Pacific Vascular Imaging Systems Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Technique
  • 5.2.2.By Procedure
  • 5.2.3.By End-User
  • 5.2.4.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Vascular Imaging Systems Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Technique
      • 5.3.1.2.2.By Procedure
      • 5.3.1.2.3.By End-User
  • 5.3.2.India Vascular Imaging Systems Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Technique
      • 5.3.2.2.2.By Procedure
      • 5.3.2.2.3.By End-User
  • 5.3.3.Australia Vascular Imaging Systems Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Technique
      • 5.3.3.2.2.By Procedure
      • 5.3.3.2.3.By End-User
  • 5.3.4.Japan Vascular Imaging Systems Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Technique
      • 5.3.4.2.2.By Procedure
      • 5.3.4.2.3.By End-User
  • 5.3.5.South Korea Vascular Imaging Systems Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Technique
      • 5.3.5.2.2.By Procedure
      • 5.3.5.2.3.By End-User

6.Europe Vascular Imaging Systems Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Technique
  • 6.2.2.By Procedure
  • 6.2.3.By End-User
  • 6.2.4.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Vascular Imaging Systems Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Technique
      • 6.3.1.2.2.By Procedure
      • 6.3.1.2.3.By End-User
  • 6.3.2.Germany Vascular Imaging Systems Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Technique
      • 6.3.2.2.2.By Procedure
      • 6.3.2.2.3.By End-User
  • 6.3.3.Spain Vascular Imaging Systems Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Technique
      • 6.3.3.2.2.By Procedure
      • 6.3.3.2.3.By End-User
  • 6.3.4.Italy Vascular Imaging Systems Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Technique
      • 6.3.4.2.2.By Procedure
      • 6.3.4.2.3.By End-User
  • 6.3.5.United Kingdom Vascular Imaging Systems Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Technique
      • 6.3.5.2.2.By Procedure
      • 6.3.5.2.3.By End-User

7.North America Vascular Imaging Systems Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Technique
  • 7.2.2.By Procedure
  • 7.2.3.By End-User
  • 7.2.4.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Vascular Imaging Systems Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Technique
      • 7.3.1.2.2.By Procedure
      • 7.3.1.2.3.By End-User
  • 7.3.2.Mexico Vascular Imaging Systems Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Technique
      • 7.3.2.2.2.By Procedure
      • 7.3.2.2.3.By End-User
  • 7.3.3.Canada Vascular Imaging Systems Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Technique
      • 7.3.3.2.2.By Procedure
      • 7.3.3.2.3.By End-User

8.South America Vascular Imaging Systems Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Technique
  • 8.2.2.By Procedure
  • 8.2.3.By End-User
  • 8.2.4.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Vascular Imaging Systems Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Technique
      • 8.3.1.2.2.By Procedure
      • 8.3.1.2.3.By End-User
  • 8.3.2.Argentina Vascular Imaging Systems Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Technique
      • 8.3.2.2.2.By Procedure
      • 8.3.2.2.3.By End-User
  • 8.3.3.Colombia Vascular Imaging Systems Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Technique
      • 8.3.3.2.2.By Procedure
      • 8.3.3.2.3.By End-User

9.Middle East and Africa Vascular Imaging Systems Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Technique
  • 9.2.2.By Procedure
  • 9.2.3.By End-User
  • 9.2.4.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Vascular Imaging Systems Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Technique
      • 9.3.1.2.2.By Procedure
      • 9.3.1.2.3.By End-User
  • 9.3.2.Saudi Arabia Vascular Imaging Systems Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Technique
      • 9.3.2.2.2.By Procedure
      • 9.3.2.2.3.By End-User
  • 9.3.3.UAE Vascular Imaging Systems Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Technique
      • 9.3.3.2.2.By Procedure
      • 9.3.3.2.3.By End-User
  • 9.3.4.Egypt Vascular Imaging Systems Market Outlook
    • 9.3.4.1.Market Size Forecast
      • 9.3.4.1.1.By Value
    • 9.3.4.2.Market Share Forecast
      • 9.3.4.2.1.By Technique
      • 9.3.4.2.2.By Procedure
      • 9.3.4.2.3.By End-User

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Merger Acquisition (If Any)
• 11.2.Product Launches (If Any)
• 11.3.Recent Developments

12.Porter's Five Forces Analysis

• 12.1.Competition in the Industry
• 12.2.Potential of New Entrants
• 12.3.Power of Suppliers
• 12.4.Power of Customers
• 12.5.Threat of Substitute Product

13.Competitive Landscape

• 13.1.Siemens Healthineers AG
  • 13.1.1.Business Overview
  • 13.1.2.Company Snapshot
  • 13.1.3.Products Services
  • 13.1.4.Financials (As Reported)
  • 13.1.5.Recent Developments
  • 13.1.6.Key Personnel Details
  • 13.1.7.SWOT Analysis
• 13.2.GE Healthcare
• 13.3.Koninklijke Philips N.V.
• 13.4.Hitachi Medical Corporation
• 13.5.Samsung Medison Co., Ltd.
• 13.6.Shimadzu Medical Systems
• 13.7.Hologic Inc.
• 13.8.Abbott Laboratories Inc.
• 13.9.OrthoScan, Inc.
• 13.10.Canon Medical Systems Corporation

14.Strategic Recommendations

15.About Us Disclaimer